Arcus biosciences to participate in the 13th annual wedbush pacgrow healthcare conference

Hayward, calif.--(business wire)--arcus biosciences (nyse:rcus), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, announced that its management team will participate in a virtual fireside chat at the upcoming 13th annual wedbush pacgrow healthcare conference. the fireside chat will take place on wednesday, august 10th, 2022 at 12:00 p.m. et. a live webcast of the fireside chat will be available by
RCUS Ratings Summary
RCUS Quant Ranking